// App-Quantinova.ai

EP1178 : TARGETED LANDSCAPE REVIEW FOR UNDERSTANDING LYMPHOMA PATIENT-REPORTED OUTCOME ASSESSMENT IN THE ERA OF EMERGING THERAPIES

Researchers

Presenter

  • Stacie Hudgens

Principal Investigators

  • Aiste Guobyte

  • Emre Yucel

  • Julia Braverman

  • Annabel Hayes

  • Fei Fei Liu

  • Catherine Bacon

  • Ariel Stevenson

  • James W. Shaw

Medical Centers

  • Clinical Outcome Assessments,Clinical Outcomes Solutions,Chicago,United States

  • Worldwide Health Economics and Outcomes Research,Bristol Myers Squibb,Princeton,United States

  • Regulatory and Access,Clinical Outcomes Solutions,Tucson,United States

  • HTA and Payer Insight,Fingerpost Consulting,Poynton,United Kingdom

  • Clinical Outcome Assessments,Clinical Outcomes Solutions,Folkestone,United Kingdom

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Obstetrics/Gynecology

Disease

  • Non-Hodgkin's Lymphoma

  • Preterm premature rupture of the membranes

Biomarkers

  • N/A

Drug/Treatment

  • Axicabtagene ciloleucel

  • Adcetris

  • tisagenlecleucel-t

  • Pembrolizumab

  • Lenalidomide

  • Idelalisib

  • Pixantrone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved